Why 1 in 3 Biopharma Launches Miss the Mark
Recent data shows that 34% of U.S. biopharma launches fail to meet their first-year forecasts. The primary culprit? A staggering 64% of industry leaders admit they lack the commercial data foundation required for success. In an increasingly competitive market, “good enough” data is no longer an option.
In February 2026, Veeva surveyed 125 senior commercial operations, analytics, marketing, and data strategy professionals to uncover the structural gaps separating successful launches from the rest.
Download the report to discover:
- Top Launch Pitfalls: Identify the data challenges currently stalling brand momentum.
- The AI Readiness Gap: Why AI investments fail without accurate, harmonized data.
- Accelerating Field Insights: How to turn fragmented data into actionable intelligence for your sales teams.
Offered Free by: Veeva Systems
See All Resources from: Veeva Systems
